Medium Entropy Alloy Biomedical Alloy: Composition Design, Mechanical Properties, And Clinical Applications

Compositional Design Principles And Phase Stability In Medium Entropy Alloy Biomedical Alloy Systems

The rational design of medium entropy alloy biomedical alloy compositions requires precise control over elemental selection, atomic percentages, and resultant phase stability to achieve biocompatibility alongside mechanical performance. Medium entropy alloys occupy a distinct thermodynamic space defined by configurational entropy (ΔS_conf) between 1.0R and 1.5R, where R represents the gas constant 81920. This entropy window permits formation of simple solid solution phases—primarily FCC, BCC, or hexagonal close-packed (HCP) structures—without precipitation of brittle intermetallic compounds that plague conventional multi-component alloys 68.

Ti-Rich Medium Entropy Alloy Biomedical Alloy Compositions For Orthopedic Implants

Titanium-rich medium entropy alloys have emerged as particularly promising biomedical alloy candidates due to titanium's inherent biocompatibility, corrosion resistance, and favorable density (4.5 g/cm³) 37. The metastable β-Ti-rich medium entropy alloy system described in patent 7 comprises Ti as the dominant element (45-80 at%) with balanced additions of Al, Cr, and Nb, formulated as Ti_x(AlCrNb)_(100-x), where the difference between Al, Cr, and Nb atomic percentages remains within 0-0.1 at% to maintain phase equilibrium 37. This composition strategy stabilizes the β-BCC phase at room temperature through β-stabilizing elements (Nb, Cr), while Al additions provide solid solution strengthening and oxidation resistance 712.

Mechanical testing of cast Ti-rich medium entropy alloy biomedical alloy specimens reveals yield strength >1100 MPa, ultimate tensile strength approaching 1250 MPa, and elastic modulus <110 GPa 7. The low elastic modulus—achieved through β-phase stabilization—represents a critical advantage over conventional Ti-6Al-4V alloy (E ≈ 110-120 GPa), reducing stress shielding that causes bone resorption around rigid implants 7. Flexural testing demonstrates bending strength >1400 MPa with flexural modulus ~60 GPa, while elastic energy storage capacity exceeds 10 MJ/m³, indicating excellent elastic recovery suitable for dynamic loading in joint replacements 7. The alloy exhibits hardness values of 380-420 HV, providing wear resistance comparable to CoCrMo alloys used in articulating surfaces 7.

Corrosion resistance testing in simulated body fluid (Hank's solution, 37°C) shows polarization resistance >1 MΩ·cm² and corrosion current density <0.1 μA/cm², outperforming Ti-6Al-4V by approximately 40% 7. Potentiodynamic polarization curves reveal passive film formation at potentials above -0.3 V vs. saturated calomel electrode (SCE), with breakdown potentials exceeding +0.8 V, confirming stable passivity across physiological pH ranges (7.2-7.6) 7. Electrochemical impedance spectroscopy (EIS) analysis indicates capacitive behavior with phase angles >80° across 0.01-100 kHz, characteristic of protective oxide layers dominated by TiO₂ and Cr₂O₃ 7.

Biodegradable ZnMgCa Medium Entropy Alloy Biomedical Alloy For Temporary Fixation Devices

Biodegradable medium entropy alloy biomedical alloy systems based on Zn-Mg-Ca compositions address the clinical need for temporary implants that eliminate secondary removal surgeries 9. The ZnMgCa medium entropy alloy disclosed in patent 9 comprises 65-85 at% Zn, 15-35 at% Mg, and 4-5 at% Ca, designed to degrade controllably in physiological environments while maintaining mechanical integrity during bone healing (typically 12-24 weeks) 9. Zinc serves as the matrix element due to its moderate corrosion rate (20-50 μm/year in vivo), essential role in bone metabolism, and acceptable cytotoxicity threshold 9. Magnesium additions accelerate degradation kinetics through galvanic coupling while contributing to new bone formation via Mg²⁺ ion release 9. Calcium incorporation (4-5 at%) promotes hydroxyapatite precipitation on implant surfaces, enhancing osseointegration 9.

The preparation method combines high-energy ball milling (350 rpm, 20 hours, Ar atmosphere) with vacuum hot-press sintering (450-500°C, 50 MPa, 2 hours) to achieve >98% theoretical density and uniform ternary phase distribution 9. Ball milling parameters—ball-to-powder ratio 10:1, stainless steel media, process control agent (1 wt% stearic acid)—prevent excessive cold welding while promoting mechanical alloying 9. Subsequent annealing treatment (300°C, 4 hours, vacuum <10⁻³ Pa) relieves residual stresses and homogenizes microstructure, improving ductility from 8% to 15% elongation 9.

Mechanical properties of sintered ZnMgCa medium entropy alloy biomedical alloy include yield strength 180-220 MPa, ultimate tensile strength 280-320 MPa, and elongation 12-18%, meeting ASTM F2180 requirements for absorbable metallic bone fixation devices (minimum yield strength 200 MPa) 9. Compression testing shows yield strength 240-280 MPa with >20% plastic deformation before fracture, suitable for load-bearing screws and pins 9. Vickers hardness ranges 110-140 HV, providing sufficient resistance to surgical handling while allowing bone remodeling forces to influence degradation 9.

In vitro degradation studies in Hank's balanced salt solution (37°C, pH 7.4, refreshed weekly) demonstrate mass loss rates of 0.15-0.25 mg/cm²/day over 28 days, corresponding to corrosion rates of 35-55 μm/year 9. Hydrogen evolution measurements yield 0.8-1.2 mL/cm²/day, below the threshold (0.01 mL/cm²/day) that causes subcutaneous gas accumulation 9. Surface analysis via scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS) reveals formation of Zn₅(OH)₈Cl₂·H₂O, Mg(OH)₂, and Ca₃(PO₄)₂ corrosion products that buffer local pH and provide bioactive surfaces 9.

Fe-Based Medium Entropy Alloy Biomedical Alloy With Enhanced Strength-Ductility Synergy

Iron-based medium entropy alloy biomedical alloy compositions offer cost advantages and magnetic resonance imaging (MRI) compatibility compared to cobalt-containing systems 12681011151920. The Cr-Fe-Co-Ni-Mo medium entropy alloy described in patents 111 comprises 3-15 at% Cr, 40-60 at% Fe, 5-20 at% Co, 5-20 at% Ni, and 3-15 at% Mo, designed to form FCC matrix with coherent Mo-rich precipitates that provide transformation-induced plasticity (TRIP) and precipitation strengthening 111. This composition achieves configurational entropy ΔS_conf ≈ 1.3R, placing it firmly within the medium entropy regime 1.

The metastable FCC phase in Cr-Fe-Co-Ni medium entropy alloys (6-15 at% Cr, 50-64 at% Fe, 13-25 at% Co, 13-25 at% Ni) undergoes deformation-induced martensitic transformation from FCC (γ) to BCC (α') during plastic deformation, activating TRIP effect that enhances work hardening and delays necking 681920. Thermodynamic calculations using CALPHAD (Calculation of Phase Diagrams) methods predict Gibbs free energy difference ΔG^(γ→α') of -50 to -150 J/mol at room temperature, indicating metastability conducive to stress-assisted transformation 819. Transmission electron microscopy (TEM) confirms α' martensite laths with thickness 20-50 nm nucleating at stacking faults and ε-martensite (HCP) interfaces during tensile testing 819.

Mechanical performance at cryogenic temperatures (77 K, liquid nitrogen) demonstrates yield strength 850-950 MPa, ultimate tensile strength 1400-1600 MPa, and elongation 45-60%, representing 50-80% improvement over equiatomic CoCrFeMnNi high-entropy alloy 681920. The exceptional cryogenic toughness—Charpy impact energy >250 J at 77 K—derives from continuous TRIP effect and nano-twinning that maintain ductility while strength increases 819. Room temperature (298 K) properties include yield strength 470-550 MPa, ultimate tensile strength 850-950 MPa, and elongation 50-65%, with strength-ductility product exceeding 50 GPa·% 681920.

Corrosion behavior in 3.5 wt% NaCl solution (simulating physiological chloride concentration) shows pitting potential +0.35 to +0.50 V vs. SCE, with passive current density 0.5-1.5 μA/cm², indicating moderate corrosion resistance requiring surface modification (e.g., anodization, plasma nitriding) for long-term implantation 111. Chromium content >10 at% ensures Cr₂O₃-rich passive films, while molybdenum additions (>5 at%) enhance pitting resistance through MoO₄²⁻ incorporation into oxide layers 111.

Microstructural Engineering And Phase Transformation Mechanisms In Medium Entropy Alloy Biomedical Alloy

Microstructural control represents a critical lever for optimizing mechanical properties and biological responses in medium entropy alloy biomedical alloy systems. The interplay between grain size, phase distribution, precipitate morphology, and defect structures (dislocations, twins, stacking faults) determines strength, ductility, fatigue resistance, and corrosion susceptibility 131416.

Grain Refinement Strategies Through Thermomechanical Processing

Thermomechanical processing routes combining cold rolling and short-duration annealing enable grain refinement to ultrafine (0.5-2 μm) or nanocrystalline (<500 nm) regimes in medium entropy alloy biomedical alloy 14. The manufacturing method disclosed in patent 14 involves: (1) arc melting or vacuum induction melting to produce homogeneous ingots; (2) homogenization heat treatment (1100-1200°C, 24 hours) to eliminate microsegregation; (3) hot rolling (900-1100°C, 50-70% thickness reduction) to break up cast dendrites; (4) cold rolling (room temperature, 70-90% reduction) to introduce high dislocation density (>10¹⁵ m⁻²); and (5) flash annealing (800-1250°C, <5 minutes) to trigger recrystallization while limiting grain growth 14.

Cold rolling to 80% reduction generates deformation bands and shear bands that serve as preferential nucleation sites for recrystallized grains during subsequent annealing 14. Electron backscatter diffraction (EBSD) mapping reveals bimodal grain size distributions after annealing at 900°C for 3 minutes: fine equiaxed grains (0.8-1.5 μm diameter) comprising 60-70% area fraction, and residual coarse grains (5-10 μm) retaining deformation substructures 14. Increasing annealing temperature to 1100°C or extending time to 10 minutes promotes abnormal grain growth, yielding average grain sizes >20 μm with reduced strength 14.

The Hall-Petch relationship quantifies grain size strengthening: Δσ_y = k_y · d^(-1/2), where k_y represents the Hall-Petch coefficient (typically 300-500 MPa·μm^(1/2) for FCC medium entropy alloys) and d denotes average grain diameter 14. Reducing grain size from 20 μm to 1 μm increases yield strength by approximately 200-300 MPa while maintaining ductility >30% through enhanced strain hardening capacity 14. Nanoindentation hardness mapping shows hardness increases from 2.8 GPa (20 μm grains) to 4.5 GPa (1 μm grains), correlating with grain boundary strengthening 14.

Hierarchical Twin Structures For Simultaneous Strength And Ductility

Hierarchical twin microstructures—comprising coarse annealing twins (width 0.5-5 μm, spacing 2-10 μm) and fine deformation twins (thickness 5-50 nm, spacing 50-200 nm)—provide exceptional combinations of strength and ductility in FCC medium entropy alloy biomedical alloy 16. Patent 16 describes twin-structured medium/high entropy alloys where annealing twins form during recrystallization (800-1100°C) due to low stacking fault energy (SFE = 15-35 mJ/m²), while deformation twins nucleate during plastic straining via partial dislocation emission from grain boundaries and annealing twin boundaries 16.

The multi-variant twin configuration creates a network of coherent Σ3 {111} boundaries that impede dislocation motion without sacrificing ductility, as twin boundaries can emit partial dislocations to accommodate strain 16. In situ TEM tensile testing reveals that deformation twins nucleate at stresses 20-30% above yield strength, thickening from initial 5 nm to 30-50 nm as strain increases from 5% to 20% 16. Twin boundary spacing decreases with strain (λ_twin ∝ ε^(-0.5)), continuously refining microstructure and sustaining high work hardening rates (dσ/dε = 2000-3000 MPa at ε = 0.1) 16.

Mechanical testing of hierarchical twin-structured CoCrMnNi medium entropy alloy demonstrates yield strength 550-650 MPa, ultimate tensile strength 950-1050 MPa, and uniform elongation 40-50%, with strength-ductility product >40 GPa·% 1316. The synergy arises from: (1) annealing twins providing initial strength through boundary strengthening (σ_twin = k_twin · λ_twin^(-1/2), k_twin ≈ 150 MPa·μm^(1/2)); (2) deformation twins activating dynamic Hall-Petch effect during straining; and (3) twin-twin intersections creating sessile dislocation locks that enhance strain hardening 16.

Spinodal Decomposition And Coherent Precipitate Strengthening

Spinodal decomposition—a diffusion-controlled phase separation mechanism occurring without nucleation barriers—enables formation of nanoscale compositional modulations that strengthen medium entropy alloy biomedical alloy while preserving ductility 5. The Cu-Fe-Mn-Al medium entropy alloy